BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.120
-0.410 (-11.61%)
At close: Jun 13, 2025, 4:00 PM
3.179
+0.059 (1.89%)
After-hours: Jun 13, 2025, 7:57 PM EDT
BriaCell Therapeutics Employees
BriaCell Therapeutics had 16 employees as of July 31, 2023. The number of employees increased by 10 or 166.67% compared to the previous year.
Employees
16
Change
10
Growth
166.67%
Revenue / Employee
n/a
Profits / Employee
-$724,500
Market Cap
21.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jul 31, 2023 | 16 | 10 | 166.67% |
| Jul 31, 2021 | 6 | 0 | - |
| Aug 1, 2019 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
BCTX News
- 9 days ago - BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26 - GlobeNewsWire
- 11 days ago - BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025 - GlobeNewsWire
- 17 days ago - BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor - GlobeNewsWire
- 21 days ago - BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025 - GlobeNewsWire
- 24 days ago - BriaCell CEO Letter to Shareholders - GlobeNewsWire
- 6 weeks ago - BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified - GlobeNewsWire
- 6 weeks ago - BriaCell Therapeutics Announces Closing of $13.8 million Public Offering - GlobeNewsWire
- 6 weeks ago - BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development - GlobeNewsWire